Joshua M Nelson
CIK 1375529 · last filed 2018-09-17
Joshua M Nelson is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for SYNH, was dated Sep 17, 2018. Across all open-market trades the lifetime net is −$2.69B, making them a net seller over the disclosed history. 12 SEC filings were submitted jointly with THOMAS H. LEE ADVISORS, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SYNH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FLOOR 35
BOSTON, MA 02110
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Syneos Health, Inc. (SYNH) Delisted | Director | 19,243,767 | $42.98 | $827.10M | -$2.69B | 2 | 2018-09-17 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-17 | Syneos Health, Inc. (SYNH) Delisted | Other (J) | −2,178 | $0 | EDGAR |
| 2018-08-13 | Syneos Health, Inc. (SYNH) Delisted | Sell (S) | −54,000,000 | -$2.69B | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.